Novaliq Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $158M

  • Investors
  • 1

Novaliq General Information

Description

Operator of a biopharmaceutical company intended to address the unmet medical needs of millions of patients with eye disease. The company's drugs focus on the development and commercialization of ocular therapeutics for dry eye disease, with products that are beneficial for the ocular surface, micro-dosed and non-preserved, targeting multiple ophthalmic diseases with a smart eye drop, enabling ophthalmologists to get a suitable option for eye treatment and preserve eyesight in millions of patients around the globe.

Contact Information

Website
www.novaliq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Im Neuenheimer Feld 515
  • 69120 Heidelberg
  • Germany
+49 06221
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Im Neuenheimer Feld 515
  • 69120 Heidelberg
  • Germany
+49 06221

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novaliq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 11-Oct-2018 $158M Completed Clinical Trials - Phase 3
4. Later Stage VC 11-Apr-2013 Completed Clinical Trials - Phase 3
3. Later Stage VC 02-May-2012 Completed Clinical Trials - Phase 3
2. Early Stage VC 15-Jul-2011 $3.29M $12.5M Completed Clinical Trials - Phase 3
1. Early Stage VC 01-Jan-2007 $9.2M $9.2M Completed Pre-Clinical Trials
To view Novaliq’s complete valuation and funding history, request access »

Novaliq Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to address the unmet medical needs of millions of patients with eye dis
Pharmaceuticals
Heidelberg, Germany
20 As of 2024

Carlsbad, CA

San Rafael, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novaliq Competitors (37)

One of Novaliq’s 37 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Astellas Pharma Corporation Tokyo, Japan
CSL Behring (Biotechnology) Corporation Vienna, Austria
You’re viewing 5 of 37 competitors. Get the full list »

Novaliq Patents

Novaliq Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026003129-A1 Stabilization of (r)-ruxolitinib Pending 26-Jun-2024
WO-2025133214-A1 Ophthalmic polypeptide compositions for the treatment of posterior eye disorders Inactive 21-Dec-2023
AU-2024371512-A1 Semifluorinated alkane compositions comprising lifitegrast Pending 02-Nov-2023
EP-4801467-A1 Semifluorinated alkane compositions comprising lifitegrast Pending 02-Nov-2023
WO-2025093739-A1 Semifluorinated alkane compositions comprising lifitegrast Inactive 02-Nov-2023 A61K9/0048
To view Novaliq’s complete patent history, request access »

Novaliq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novaliq Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dievini Venture Capital Minority
To view Novaliq’s complete investors history, request access »

Novaliq Investments (1)

Novaliq’s most recent deal was a Joint Venture with Betaliq. The deal was made on 10-Oct-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Betaliq 10-Oct-2018 Joint Venture Drug Discovery
To view Novaliq’s complete investments history, request access »

Novaliq FAQs

  • When was Novaliq founded?

    Novaliq was founded in 2007.

  • Where is Novaliq headquartered?

    Novaliq is headquartered in Heidelberg, Germany.

  • What is the size of Novaliq?

    Novaliq has 20 total employees.

  • What industry is Novaliq in?

    Novaliq’s primary industry is Pharmaceuticals.

  • Is Novaliq a private or public company?

    Novaliq is a Private company.

  • What is Novaliq’s current revenue?

    The current revenue for Novaliq is .

  • How much funding has Novaliq raised over time?

    Novaliq has raised $194M.

  • Who are Novaliq’s investors?

    Dievini has invested in Novaliq.

  • Who are Novaliq’s competitors?

    Renova Therapeutics, BioMarin Pharmaceutical, Intas Pharmaceuticals, Astellas Pharma, and CSL Behring (Biotechnology) are some of the 37 competitors of Novaliq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process